Drug Innovation or Contamination?

As harm reduction has risen in prominence and influence in the addiction, treatment, and recovery spaces, one of its contributions to discussions about public policy related to drug use has been the suggestion that prohibition creates a drug supply with unpredictable potency that is vulnerable to contamination, and that these factors drive overdose. This leads … Continue reading Drug Innovation or Contamination?

Drug “poisoning” or “overdose”?

The NY Times has an article on the debate between characterizing drug deaths, fentanyl deaths in particular, as poisonings or overdoses. Much of the argument focuses on destigmatizing drug-related deaths. “If I tell someone that my child overdosed, they assume he was a junkie strung out on drugs,” said Stefanie Turner, a co-founder of Texas Against … Continue reading Drug “poisoning” or “overdose”?

Drug apartheid, pro-drug cultures, wellness boosters, and sober drug use

This week produced an interesting collection of articles about drugs, their place in society, and drug policy. I thought they were worth sharing because they paint a picture of the contradictions of the moment we're living in. Drug Apartheid On Tuesday, TalkingDrugs, an international drug policy advocacy news platform, published an article proposing apartheid as … Continue reading Drug apartheid, pro-drug cultures, wellness boosters, and sober drug use

BC safer supply associated with an increase in hospitalizations (but not deaths)

JAMA Internal Medicine just published a study on the impact of a safer supply program. First the background: In March 2020, British Columbia became the first jurisdiction globally to launch a provincewide Safer Opioid Supply policy that allows individuals at high risk of overdose to receive pharmaceutical-grade opioids free of charge prescribed by a physician … Continue reading BC safer supply associated with an increase in hospitalizations (but not deaths)